Bluejay Diagnostics, Inc. Interest Expense Nonoperating
Bluejay Diagnostics, Inc. (BJDX) reported Interest Expense Nonoperating of $839 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-03-06
- Bluejay Diagnostics, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $187.00, a 74.35% decline year-over-year.
- Bluejay Diagnostics, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $200.00, a 99.90% decline year-over-year.
- Bluejay Diagnostics, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $222.00, a 99.96% decline year-over-year.
- Bluejay Diagnostics, Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $230.00.
- Bluejay Diagnostics, Inc. interest expense nonoperating for fiscal 2025 was $839.00, a 99.90% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. interest expense nonoperating for fiscal 2024 was $823.03K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $187.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $387.00 derived: sum of 2 quarters · filed 2026-03-06 | $609.00 derived: sum of 3 quarters · filed 2026-03-06 | $839.00 10-K · filed 2026-03-06 |
| 2025-09-30 | $200.00 10-Q · filed 2025-11-07 | $422.00 derived: sum of 2 quarters · filed 2025-11-07 | $652.00 10-Q · filed 2025-11-07 | $1.38K derived: sum of 4 quarters · filed 2026-03-06 |
| 2025-06-30 | $222.00 10-Q · filed 2025-08-07 | $452.00 10-Q · filed 2025-08-07 | $1.18K derived: sum of 3 quarters · filed 2026-03-06 | $191.79K derived: sum of 4 quarters · filed 2026-03-06 |
| 2025-03-31 | $230.00 derived: 10-K 12 month − 3 quarters · filed 2026-03-06 | $959.00 derived: sum of 2 quarters · filed 2026-03-06 | $191.57K derived: sum of 3 quarters · filed 2026-03-06 | $818.04K derived: sum of 4 quarters · filed 2026-03-06 |
| 2024-12-31 | $729.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $191.34K derived: sum of 2 quarters · filed 2026-03-06 | $817.81K derived: sum of 3 quarters · filed 2026-03-06 | $823.03K 10-K · filed 2026-03-06 |
| 2024-09-30 | $190.61K 10-Q · filed 2025-11-07 | $817.08K derived: sum of 2 quarters · filed 2025-11-07 | $822.30K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $626.47K 10-Q · filed 2025-08-07 | $631.69K 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |